What is the recommended metronidazole dose per kilogram for adults and children, including adjustments for severe hepatic impairment and renal failure, and the typical treatment durations for common infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole Dosing Per Kilogram

For adults, metronidazole is dosed at 500 mg orally three times daily (approximately 7.5 mg/kg/dose for an average 70 kg adult), while pediatric patients require 30-40 mg/kg/day divided every 8 hours with a maximum single dose of 500 mg for most infections. 1

Adult Dosing

Standard Infections

  • 7.5 mg/kg/dose (500 mg) orally three times daily for 10 days is the typical regimen for most anaerobic infections 2
  • For severe infections requiring IV therapy, 500 mg IV every 8 hours is recommended 2

Clostridium difficile Infection (CDI)

  • Metronidazole is no longer first-line therapy for CDI; vancomycin or fidaxomicin are preferred 2, 3
  • If metronidazole must be used due to limited access: 500 mg orally three times daily for 10 days for nonsevere CDI only 2
  • For fulminant CDI with ileus: 500 mg IV every 8 hours combined with oral or rectal vancomycin 2, 1

Pediatric Dosing

Standard Dosing (Children >1 month)

  • 30-40 mg/kg/day divided every 8 hours with a maximum single dose of 500 mg 1
  • This translates to approximately 10-13 mg/kg/dose every 8 hours 1

Condition-Specific Pediatric Dosing

Clostridium difficile Infection:

  • Non-severe CDI: 7.5 mg/kg/dose three or four times daily (maximum 500 mg/dose) for 10 days 1
  • Severe CDI requiring IV: 10 mg/kg/dose three times daily (maximum 500 mg/dose) 1
  • Note that CDI dosing is lower than for other anaerobic infections 1

Intra-abdominal Infections:

  • 30-40 mg/kg/day divided every 8 hours as part of combination therapy with gram-negative coverage 1
  • Always combine with aminoglycosides, carbapenems, or advanced-generation cephalosporins 1

Necrotizing Infections:

  • 7.5 mg/kg/dose every 6 hours IV combined with cefotaxime or other broad-spectrum agents 1

Crohn's Disease (Perianal Fistulizing):

  • 10-20 mg/kg/day in divided doses 1

Neonatal Dosing

  • Postnatal age ≤7 days, weight ≤2000 g: 7.5 mg/kg every 12 hours 1
  • Postnatal age ≤7 days, weight >2000 g: 7.5-10 mg/kg every 12 hours 1
  • Postnatal age >7 days, weight <1200 g: 7.5-10 mg/kg every 8-12 hours 1
  • Postnatal age >7 days, weight >2000 g: 10 mg/kg every 8 hours 1

Dosing Adjustments

Hepatic Impairment

  • Severe hepatic dysfunction requires dose reduction due to significantly prolonged half-life (up to 42.4 hours vs. 5.9 hours in normal function) 4, 5
  • Patients with obstructive liver disease show the lowest clearances (0.281-1.17 ml/min/kg) and require careful monitoring 5
  • Consider reducing dose by 50% or extending dosing intervals in severe hepatic impairment 4

Renal Failure

  • No dosage adjustment needed for the parent drug as metronidazole pharmacokinetics are unaffected by renal failure 3, 6, 7
  • Metabolites accumulate in renal dysfunction but have not been associated with documented toxicity 6, 7
  • Hemodialysis removes substantial amounts of metronidazole; consider supplemental dosing post-dialysis 7

Treatment Duration and Safety

Standard Duration

  • 10 days is the typical treatment course for most infections 2, 1
  • For amebiasis: 5-10 days 1

Critical Safety Warning

  • Avoid repeated or prolonged courses beyond 10 days due to risk of cumulative and potentially irreversible neurotoxicity (peripheral neuropathy, seizures, encephalopathy) 2, 3, 1
  • Patients receiving therapy >10 days require close monitoring for neurotoxic signs 1

Common Pitfalls to Avoid

  • Do not use metronidazole as monotherapy for intra-abdominal infections—always pair with gram-negative/aerobic coverage 1
  • Do not select metronidazole as first-line for CDI—prioritize vancomycin (125 mg four times daily) or fidaxomicin (200 mg twice daily) 2
  • Do not exceed 500 mg per single dose in pediatric patients regardless of weight-based calculations 1
  • Do not continue beyond 10 days without compelling justification due to neurotoxicity risk 3, 1
  • For fulminant CDI with ileus, do not rely on oral metronidazole alone—use IV metronidazole combined with oral/rectal vancomycin 2, 1

References

Guideline

Pediatric Metronidazole Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Metronidazole Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metronidazole: pharmacokinetic observations in severely ill patients.

The Journal of antimicrobial chemotherapy, 1984

Related Questions

What is the appropriate metronidazole (Flagyl) dosing regimen for uncomplicated bacterial or protozoal gastroenteritis in an adult, and how should the dose be adjusted for children, severe hepatic impairment, moderate‑to‑severe renal failure, pregnancy, and lactation?
What is the recommended dosage of metronidazole for an adult patient when administered intravenously?
What is the role of metronidazole in a patient with acute liver failure, cholecystitis, and impaired renal function, suspected of having an anaerobic infection?
Can metronidazole be given to a patient with sepsis, potential vascular disease, and impaired renal function, who is being treated with Zosyn (piperacillin/tazobactam)?
What is the bioavailability of oral vs intravenous (IV) metronidazole?
What are the local and systemic side effects of bioidentical estradiol pellets, and are they effective for weight management?
What are the side effects of selective alpha‑1 blockers such as prazosin, terazosin, doxazosin, tamsulosin, and alfuzosin?
In an adult bipolar patient without hepatic disease, renal impairment, bone‑marrow suppression, or severe hyponatremia, what are carbamazepine’s indications, starting dose and titration schedule, therapeutic serum level range, required monitoring, and criteria for discontinuation?
In patients admitted to the intensive care unit, should sodium‑glucose cotransporter‑2 (SGLT‑2) inhibitors be discontinued, and what criteria allow safe restarting?
What are the metabolic effects of bioidentical progesterone pellets in postmenopausal women?
What is the recommended outpatient management for a patient who has experienced a transient ischemic attack?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.